Durham biotech CoImmune (formerly Argos) acquires cancer-focused pharma
CoImmune, the name for the former Argos Therapeutics which was acquired by two South Korean firms last year, is growing larger.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
